- UroToday Home
- Recent Abstracts
- Urologic Oncology
Renal Cancer
Characterization of the expression of LAT1 as a prognostic indicator and a therapeutic target in renal cell carcinoma.
November 29, 2019
Upregulation of ERp57 promotes clear cell renal cell carcinoma progression by initiating a STAT3/ILF3 feedback loop.
November 29, 2019
Predicting Adherent Perinephric Fat Using Preoperative Clinical and Radiological Factors in Patients Undergoing Partial Nephrectomy.
November 29, 2019
The association of anxiety and depression with perioperative and oncologic outcomes among patients with clear cell renal cell carcinoma undergoing nephrectomy.
November 28, 2019
Rational Approaches to Treatment Duration with Immunotherapy in Metastatic Renal Cell Carcinoma.
November 28, 2019
Sunitinib cause delayed complete response on metastatic RCC and extensive IVC thrombus, but not to the kidney tumor: a case report and review of literature.
November 28, 2019
Bioplasmonic paper-based assay for perilipin-2 non-invasively detects renal cancer.
November 27, 2019
miR-22 Regulates Invasion, Gene Expression and Predicts Overall Survival in Patients with Clear Cell Renal Cell Carcinoma.
November 27, 2019
Improving IMDC Prognostic Prediction Through Evaluation of Initial Site of Metastasis in Patients With Metastatic Renal Cell Carcinoma.
November 26, 2019
Eligibility and Radiologic Assessment for Adjuvant Clinical Trials in Kidney Cancer.
November 26, 2019
Renal fossa recurrence after radical nephrectomy: Current management, and oncological outcomes.
November 25, 2019
Prognostic value of risk stratification using blood parameters for nivolumab in Japanese patients with metastatic renal-cell carcinoma.
November 25, 2019
New immunotherapy in the treatment of advanced renal cancer.
November 25, 2019
HIF-2 Complex Dissociation, Target Inhibition, and Acquired Resistance with PT2385, a First-in-Class HIF-2 Inhibitor in Clear Cell Renal Cell Carcinoma Patients.
November 22, 2019
The Role of Cytoreductive Nephrectomy for Sarcomatoid Renal Cell Carcinoma: A 29-year Institutional Experience.
November 22, 2019
A Pilot Study of Radiation Therapy in Combination With Pembrolizumab in Patients With Metastatic Renal Cell Cancer.
November 22, 2019